Edinburgh University spin-out Resolution Therapeutics has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a trial of its lead candidate RTX001 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback